Sale!

AP2S1 Gene Hypocalciuric Hypercalcemia Familial Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AP2S1 gene plays a critical role in calcium regulation within the body, and mutations in this gene can lead to a rare condition known as familial hypocalciuric hypercalcemia type 3 (FHH3). This genetic disorder is characterized by elevated calcium levels in the blood while maintaining low levels of calcium in the urine, a condition that can lead to various health issues if not properly managed.

To diagnose FHH3, a genetic test targeting the AP2S1 gene is available at DNA Labs UAE. This test involves analyzing the DNA to identify mutations in the AP2S1 gene that are responsible for the condition. It is a crucial step for families with a history of hypercalcemia to understand their genetic makeup and manage the condition effectively.

The cost of the AP2S1 gene hypocalciuric hypercalcemia familial type 3 genetic test at DNA Labs UAE is 4400 AED. This investment allows individuals and families to gain valuable insights into their genetic predisposition to FHH3, facilitating early intervention and personalized management strategies to mitigate the impact of this condition on their health and lifestyle.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AP2S1 Gene Hypocalciuric Hypercalcemia Familial Type 3 Genetic Test

Test Details

The AP2S1 gene is associated with a genetic condition called hypocalciuric hypercalcemia, familial type 3. This condition is characterized by high levels of calcium in the blood (hypercalcemia) and low levels of calcium in the urine (hypocalciuria).

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of hypocalciuric hypercalcemia, NGS genetic testing can be used to identify mutations or variations in the AP2S1 gene that may be responsible for the condition.

By identifying these genetic variations, NGS testing can help confirm a diagnosis of familial type 3 hypocalciuric hypercalcemia and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of the condition.

It’s important to note that genetic testing should always be done under the guidance of a healthcare professional, who can interpret the results and provide appropriate counseling and care.

Test Name

AP2S1 Gene Hypocalciuric hypercalcemia familial type 3 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Metabolic Disorders

Doctor

General Physician

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for AP2S1 Gene Hypocalciuric hypercalcemia, familial type 3 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Hypocalciuric hypercalcemia, familial type 3

Test Name AP2S1 Gene Hypocalciuric hypercalcemia familial type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AP2S1 Gene Hypocalciuric hypercalcemia, familial type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypocalciuric hypercalcemia, familial type 3
Test Details

The AP2S1 gene is associated with a genetic condition called hypocalciuric hypercalcemia, familial type 3. This condition is characterized by high levels of calcium in the blood (hypercalcemia) and low levels of calcium in the urine (hypocalciuria).

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of hypocalciuric hypercalcemia, NGS genetic testing can be used to identify mutations or variations in the AP2S1 gene that may be responsible for the condition.

By identifying these genetic variations, NGS testing can help confirm a diagnosis of familial type 3 hypocalciuric hypercalcemia and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of the condition.

It’s important to note that genetic testing should always be done under the guidance of a healthcare professional, who can interpret the results and provide appropriate counseling and care.